Atlas Trials

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Clinical trial NCT05572645 · COMPLETED

Trial details

NCT number
NCT05572645
Sponsor
Fudan University
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-10-01
Primary completion
2023-09-01
Enrollment
333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.